Regulatory Artwork Excellence for the Global Life Sciences Industry

In the highly regulated life sciences environment, artwork accuracy is not just about visual appeal it is central to patient safety, regulatory compliance, and brand trust. Masuu Global Solutions delivers end to end regulatory artwork services with unmatched precision, quality, and compliance, supporting pharmaceuticals, medical devices, and consumer healthcare organizations worldwide.

Regulatory Artwork Simplified for Life Sciences

Artwork is a critical communication tool, serving as the bridge between manufacturers and end users. Accurate labeling, compliant design, and clear instructions directly influence:
  • Patient outcomes
  • Safe device use
  • Product perception
  • Regulatory acceptance

Masuu’s artwork services provide seamless, compliant, and intelligently structured artwork solutions from content creation to packaging design, from digital to print, and from artwork development to full lifecycle management.

Life Sciences Industry Focus

Masuu Global Solutions specializes in artwork services across:
  • Medical Devices (MD)
  • Pharmaceuticals (Rx/OTC)
  • Consumer Healthcare (CHC)

Our artwork solutions integrate regulatory intelligence, design expertise, and process automation—empowering companies to accelerate time to market and ensure artwork readiness across global markets.

Masuu’s Regulatory Artwork Solutions – Overview

Masuu provides fast, compliant, and high precision artwork services for life sciences companies. Our end to end offerings cover:
  • Artwork creation
  • Artwork updates & revisions
  • End to end lifecycle management
  • Regulatory proofreading
  • Content and labeling compliance
  • Promotional artwork design
  • Packaging & carton development
  • Technology-enabled artwork process management

We help ensure every artwork element aligns with the latest regulatory, quality, and branding requirements—supporting faster approvals and stronger market presence.

Why Regulatory Artwork Matters Across Sectors

Medical Devices

Medical device artwork plays a critical role in labeling, UDI accuracy, packaging integrity, and IFU clarity. Masuu ensures:
  • MDR/IVDR aligned artwork content
  • Elimination of compliance errors
  • Clear communication for safe device use
  • Efficient updates across global markets

Pharmaceuticals

From content to carton, Masuu ensures every artwork component meets regulatory expectations:
  • Packaging artwork design
  • Labeling & artboard compliance
  • Artwork lifecycle management
  • Proofreading & QC
  • Artwork studio & staffing support
  • Digital artwork transition support

Consumer Goods

For consumer healthcare and OTC brands, artwork must be:
  • Visually appealing
  • Compliance driven
  • Consistent across languages & regions
  • Clear, accessible, and user friendly

Masuu delivers all of the above—helping brands stand out while staying compliant.

The Masuu Advantage

  1. Fully Compliant Artwork
  2. We ensure artwork is created, reviewed, and approved in accordance with global regulatory requirements from concept to commercialization.
  1. Zero Tolerance for Errors
  2. Every single component from labels and inserts to cartons, IFUs, and online content—undergoes meticulous review and multiple QC checkpoints.
  1. Expertise Across Regulations
  2. Our artwork specialists bring deep expertise in:
    • EU MDR/IVDR
    • FDA labeling requirements
    • GCC, APAC, LATAM labeling norms
    • Global regulatory artwork standards
  1. Faster Time to Market
  2. Masuu delivers accurate artwork updates on time enabling quick turnarounds for launches, re labelling, and market expansion.
  1. Technology Driven Artwork Solutions
  2. We leverage:
    • Artwork management platforms
    • Digital workflow automation
    • AI assisted proofreading tools
    • Version control & traceability systems
    This ensures speed, consistency, and efficient lifecycle management.
  1. Complete Artwork Lifecycle Support
  2. From content development to final print ready files, Masuu manages:
    • Content harmonization
    • Regulatory review
    • Multilanguage artwork
    • Global artwork adaptation
    • Stakeholder coordination

We ensure your artwork remains compliant, accurate, and aligned with evolving regulatory standards.

Partner with Masuu Global Solutions

Masuu enables life sciences companies to:
  • Stay compliant across global markets
  • Strengthen brand presence
  • Enhance artwork accuracy & quality
  • Avoid costly errors or recalldriven redesigns
  • Accelerate product launch timelines

Our approach ensures you receive reliable, scale ready and fully compliant artwork services—empowering your brand to succeed in competitive regulatory environments.

Frequently Asked Questions

Regulatory artwork services cover the creation, review, revision, and lifecycle management of artwork used for medical device labeling, packaging, IFUs, and related materials. The process ensures that required information is accurately presented and aligned with applicable regulatory and quality requirements, including requirements relevant to medical device labeling, UDI, packaging, and instructions for use.

Medical device artwork should be reviewed against the applicable EU MDR or IVDR labeling and information requirements, including required product information, identifiers, symbols, warnings, instructions, and other applicable content. Artwork review should also verify consistency with technical documentation and approved regulatory information before the final artwork is released for production.

Regulatory proofreading should verify the accuracy and consistency of required labeling content, product information, warnings, instructions, symbols, identifiers, and other applicable regulatory details. The review should also check formatting, language versions, omissions, inconsistencies, and changes against approved source content. Documented quality checks and version control help maintain traceability throughout the artwork lifecycle.

Artwork management provides controlled processes for creating, reviewing, approving, revising, and distributing labeling and packaging materials. It helps maintain consistency between approved regulatory content and production artwork while providing version control and traceability. This becomes particularly important when devices are updated, relabeled, translated, or introduced into additional markets.

Global artwork changes require the approved content to be reviewed against the regulatory and language requirements of each target market. Changes should be controlled so that country-specific versions remain consistent with the applicable regulatory information while accommodating local requirements. Version control, traceability, regulatory review, and stakeholder coordination help prevent inconsistencies between market-specific artworks.

Medical device artwork can include product labels, packaging and cartons, instructions for use, inserts, and other materials communicating information to users or supply-chain stakeholders. Depending on the device and market, artwork may contain product identification, regulatory information, warnings, instructions, symbols, and other required content that must remain consistent with approved documentation.

UDI-related information should be incorporated accurately into applicable medical device labeling and packaging and maintained consistently through artwork revisions. Artwork reviews should verify that identifiers and related information correspond with the approved product and regulatory documentation. Controlled version management is particularly important when artwork is updated for product, packaging, or market changes.

Multilingual artwork requires accurate translation and careful review of regulatory content across each language version. Translated information should remain consistent with the approved source content while accommodating applicable country-specific requirements. Regulatory proofreading, terminology consistency, version control, and cross-language quality checks can help reduce discrepancies between language versions and support compliant global commercialization.

Artwork may require revision when approved labeling information, regulatory requirements, product details, packaging, instructions, identifiers, or market requirements change. Artwork should also be reviewed when regulatory updates or product lifecycle changes affect existing content. Each revision should follow a controlled review and approval process to maintain accurate, traceable, and current artwork.

Regulatory artwork lifecycle management covers artwork development, regulatory review, proofreading, approval, revisions, localization, version control, and maintenance through commercialization. It helps ensure that labels, packaging, IFUs, and related materials remain aligned with current regulatory and product information. The process can support medical devices, pharmaceuticals, and consumer healthcare products across multiple markets.

Book a Demo